Effect of calcitriol in combination with corticosterone, interleukin- 1β, and transforming growth factor-β1 on nerve growth factor secretion in an astroglial cell line

Journal of Neurochemistry

Volumn 69, Issue 1, 1997, Pages 102-109

  Hahn, Martina ^a   Lorez, Hanspeter ^a   Fischer, Günther ^a,b  

^a Preclinical Research   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Astroglial cell line; Calcitriol; Corticosterone; Interleukin 1 ; Nerve growth factor; Transforming growth factor 1

Indexed keywords

CORTICOSTERONE; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; HORMONAL REGULATION; MACROGLIA; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY NERVE; SYMPATHETIC NERVE;

ANIMALIA; TRIXIS;

EID: 0030942748     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69010102.x     Document Type: Article

References (72)

1. Adams J. S., Ren S.-Y., Arbelle J. E., Horiuchi N., Gray R. W., Clemens T. L., and Shany S. (1994) Regulated production and intracrine action of 1,25-dihydroxyvitamin D3 in the chick myelomonocytic cell line HD-11. Endocrinology 134, 2567-2573.
2. Aloe L. (1989) Adrenalectomy decreases nerve growth factor in young adult rat hippocampus. Proc. Natl. Acad. Sci. USA 86, 5636-5640.
3. Ayer-LeLievre C., Olson L., Ebendal T., Seiger A., and Persson H. (1988) Expression of the beta-nerve growth factor gene in hippocampal neurons. Science 240, 1339-1341.
4. Bacia A., Aloe L., Fusco M., Vantini G., Leon A., and Oderfeld-Nowak B. (1992) Cellular localization of nerve growth factor-like immunoreactivity in hippocampus and septum of adult rat brain. Acta Neurobiol. Exp. (Warsz.) 52, 1-7.
5. Bakhit C., Armanini M., Bennett G. L., Wong W. L., Hansen S. E., and Taylor R. (1991) Increase in glia-derived nerve growth factor following destruction of hippocampal neurons. Brain Res. 560, 76-83.
6. Bandtlow C. E., Meyer M., Lindholm D., Spranger M., Heumann R., and Thoenen H. (1990) Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J. Cell Biol. 111, 1701-1711.
7. Barbany G. and Persson H. (1992) Regulation of neurotrophin mRNA expression in the rat brain by glucocorticoids. Eur. J. Neurosci. 4, 396-403.
8. Berth-Jones J. and Hutchinson P. E. (1992) Vitamin D analogues and psoriasis. Br. J. Dermatol. 127, 71-78.
9. Bhalla A. K., Amento E. P., and Krane S. M. (1986) Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol. 98, 311-322.
10. Bonewald L. F., Kester M. B., Schwartz Z., Swain L. D., Khare A., Johnson T. L., Leach R. J., and Boyan B. D. (1992a) Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267, 8943-8949.
11. Bonewald L. F., Schwartz Z., Swain L. D., and Boyan B. D. (1992b) Stimulation of matrix vesicle enzyme activity in osteoblast-like cells by 1,25(OH)2D3 and transforming growth factor beta (TGF beta). Bone Miner. 17, 139-144.
12. Choi D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 1261-1276.
13. De Kloet E. R. (1992) Corticosteroids, stress, and aging. Ann. NY Acad. Sci. 663, 357-371.
14. Dunn A. J. (1992) The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29, 807-812.
15. Ernfors P., Wetmore C., Olson L., and Persson H. (1990) Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5, 511-526.
16. Fischer W., Wictorin K., Bjorklund A., Williams L. R., Varon S., and Gage F. H. (1987) Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65-68.
17. Friedman W. J., Larkfors L., Ayer-LeLievre C., Ebendal T., Olson L., and Persson H. (1990) Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J. Neurosci. Res. 27, 374-382.
18. Fukumoto H., Kakihana M., and Suno M. (1991) Recombinant human basic fibroblast growth factor (rhbFGF) induces secretion of nerve growth factor (NGF) in cultured rat astroglial cells. Neurosci. Lett. 122, 221-224.
19. Gage F. H., Chen K. S., Buzsaki G., and Armstrong D. (1988) Experimental approaches to age-related cognitive impairments. Neurobiol. Aging 9, 645-655.
20. Griffin W. S., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. III, and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
21. Gyetko M. R., Hsu C. H., Wilkinson C. C., Patel S., and Young E. (1993) Monocyte 1a-hydroxylase regulation: induction by inflammatory cytokines and suppression by dexamethasone and uremic toxin. J. Leukocyte Biol. 53, 17-22.
22. Hahn M., Lorez H., and Fischer G. (1994) The immortalized astroglial cell line RC7 is a new model system for the study of nerve growth factor (NGF) regulation: stimulation by interleukin-1β and transforming growth factor-β1 is additive and affected differently by dibutyryl cyclic AMP. Glia 10, 286-295.
23. Hustmyer F. G., Girasole G., and Manolagas S. C. (1992) Signal-dependent pleiotropic regulation of lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3: potent modulation of the hormonal effects by phorbol esters. Immunology 77, 520-526.
24. Jat P. S. and Sharp P. A. (1986) Large T antigens of simian virus 40 and polyomavirus efficiently establish primary fibroblasts. J. Virol. 59, 746-750.
25. Jehan F., Neveu I., Barbot N., Binderup L., Brachet P., and Wion D. (1991) MC903, an analogue of 1,25-dihydroxyvitamin D3, increases the synthesis of nerve growth factor. Eur. J. Pharmacol. 208, 189-191.
26. Jehan F., Neveu I., Naveilhan P., Brachet P., and Wion D. (1993) Complex interactions among second messenger pathways, steroid hormones, and protooncogenes of the Fos and Jun families converge in the regulation of the nerve growth factor gene. J. Neurochem. 60, 1843-1853.
27. Jehan F., Naveilhan P., Neveu I., Harvie D., Dicou E., Brachet P., and Wion D. (1996) Regulation of NGF, BDNF and LNGFR gene expression in ROS 17/2.8 cells. Mol. Cell. Endocrinol. 116, 149-156.
28. Kesner R. P. (1988) Reevaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiol. Aging 9, 609-616.
29. Kiefer R., Lindholm D., and Kreutzberg G. W. (1993) Interleukin-6 and transforming growth factor-beta 1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur. J. Neurosci. 5, 775-781.
30. Kim H. J., Abdelkader N., Katz M., and McLane J. A. (1992) 1,25-Dihydroxyvitamin-D3 enhances antiproliferative effect and transcription of TGF-betal on human keratinocytes in culture. J. Cell Physiol. 151, 579-587.
31. Koli K. and Keski-Oja J. (1993) Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes. Growth Factors 8, 153-163.
32. Korsching S. and Thoenen H. (1983) Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation. Proc. Natl. Acad. Sci. USA 80, 3513-3516.
33. Lapchak P. A., Araujo D. M., Carswell S., and Hefti F. (1993) Distribution of [125I] nerve growth factor in the rat brain following a single intraventricular injection: correlation with the topographical distribution of trkA messenger RNA-expressing cells. Neuroscience 54, 445-460.
34. Lefebvre P. P., Martin D., Staecker H., Weber T., Moonen G., and Van de Water T. R. (1992) TGF beta 1 expression is initiated in adult auditory neurons by sectioning of the auditory nerve. Neuroreport 3, 295-298.
35. Lemire J. M., Archer D. C., and Reddy G. S. (1994) 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135, 2818-2821.
36. Lindholm D., Hengerer B., Zafra F., and Thoenen H. (1990) Transforming growth factor-beta 1 stimulates expression of nerve growth factor in the rat CNS. Neuroreport 1, 9-12.
37. Lindholm D., Castren E., Kiefer R., Zafra F., and Thoenen H. (1992) Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117, 395-400.
38. Liu T., McDonnell P. C., Young P. R., White R. F., Siren A. L., Hallenbeck J. M., Barone F. C., and Feurestein G. Z. (1993) Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke 24, 1746-1750.
39. Mann R., Mulligan R. C., and Baltimore D. (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
40. Morgan T. E., Nichols N. R., Pasinetti G. M., and Finch C. E. (1993) TGF-beta 1 mRNA increases in macrophage/microglial cells of the hippocampus in response to deafferentation and kainic acid-induced neurodegeneration. Exp. Neurol. 120, 291-301.
41. Naveilhan P., Neveu I., Wion D., and Brachet P. (1996) 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7, 2171-2175.
42. Neveu I., Barbot N., Jehan F., Wion D., and Brachet P. (1991) Antagonistic effects of dexamethasone and 1,25-dihydroxyvitamin D3 on the synthesis of nerve growth factor. Mol. Cell. Endocrinol. 78, R1-R6.
43. Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., De Luca H. F., and Brachet P. (1994a) 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Mol. Brain Res. 24, 70-76.
44. Neveu I., Naveilhan P., Menaa C., Wion D., Brachet P., and Garabedian M. (1994b) Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J. Neurosci. Res. 38, 214-220.
45. Neveu I., Naveilhan P., Baudet C., Brachet P., and Metsis M. (1994c) 1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 6, 124-126.
46. Nichols N. R., Laping N. J., Day J. R., and Finch C. E. (1991) Increases in transforming growth factor-beta mRNA in hippocampus during response to entorhinal cortex lesions in intact and adrenalectomized rats. J. Neurosci. Res. 28, 134-139.
47. Oderfeld-Nowak B., Bacia A., Gradkowska M., Fusco M., Vantini G., Leon A., and Aloe L. (1992) In vivo activated brain astrocytes may produce and secrete nerve growth factor-like molecules. Neurochem. Int. 21, 455-461.
48. Olson L. (1993) NGF and the treatment of Alzheimer's disease. Exp. Neurol. 124, 5-15.
49. Olton D. S. (1988) Aging and spatial cognition. Neurobiol. Aging 9, 569-570.
50. Pasinetti G. M., Nichols N. R., Tocco G., Morgan T., Laping N., and Finch C. E. (1993) Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience 54, 893-907.
51. Petkovich P. M., Wrana J. L., Grigoriadis A. E., Heersche J. N., and Sodek J. (1987) 1,25-Dihydroxyvitamin D3 increases epidermal growth factor receptors and transforming growth factor beta-like activity in a bone-derived cell line. J. Biol. Chem. 262, 13424-13428.
52. Pshenichkin S. P., Szekely A. M., and Wise B. C. (1994) Transcriptional and posttranscriptional mechanisms involved in the interleukin-1, steroid, and protein kinase C regulation of nerve growth factor in cortical astrocytes. J. Neurochem. 63, 419-428.
53. Rothwell N. J. (1991) Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 12, 430-436.
54. Saporito M. S. and Carswell S. (1995) High levels of synthesis and local effects of nerve growth factor in the septal region of the adult rat brain. J. Neurosci. 15, 2280-2286.
55. Saporito M. S., Wilcox H. M., Hartpence K. C., Lewis M. E., Vaught J. L., and Carswell S. (1993) Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp. Neurol. 123, 295-302.
56. Saporito M. S., Brown E. R., Hartpence K. C., Wilcox H. M., Vaught J. L., and Carswell S. (1994) Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain. Brain Res. 633, 189-196.
57. Sato T., Ono T., and Tuan R. S. (1993) 1,25-Dihydroxy vitamin D3 stimulation of TGF-beta expression in chick embryonic calvarial bone. Differentiation 52, 139-150.
58. Schneider H. G., Michelangeli V. P., Frampton R. J., Grogan J. L., Ikeda K., Martin T. J., and Findlay D. M. (1992) Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Endocrinology 131, 1383-1389.
59. Scully J. L. and Otten U. (1993) Glucocorticoid modulation of neurotrophin expression in immortalized mouse hippocampal neurons. Neurosci. Lett. 155, 11-14.
60. Sonnenberg J., Luine V. N., Krey L. C., and Christakos S. (1986) 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology 118, 1433-1439.
61. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Näher-Noé M., and Thoenen H. (1990) Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2, 69-76.
62. Thoenen H., Bandtlow C., and Heumann R. (1987) The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109, 145-178.
63. Thoenen H., Zafra F., Hengerer B., and Lindholm D. (1991) The synthesis of nerve growth factor and brain-derived neurotrophic factor in hippocampal and cortical neurons is regulated by specific transmitter systems. Ann. NY Acad. Sci. 640, 86-90.
64. Tocco M. D., Contreras M. L., Koizumi S., Dickens G., and Guroff G. (1988) Decreased levels of nerve growth factor receptor on dexamethasone-treated PC12 cells. J. Neurosci. Res. 20, 411-419.
65. Turnbull A. V., Dow R. C., Hopkins S. J., White A., Fink G., and Rothwell N. J. (1994) Mechanisms of activation of the pituitary-adrenal axis by tissue injury in the rat. Psychoneuroendocrinology 19, 165-178.
66. Whittemore S. R., Friedman P. L., Larhammar D., Persson H., Gonzalez-Carvajal M., and Holets V. R. (1988) Rat beta-nerve growth factor sequence and site of synthesis in the adult hippocampus. J. Neurosci. Res. 20, 403-410.
67. Wion D., MacGrogan D., Neveu I., Jehan F., Houlgatte R., and Brachet P. (1991) 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J. Neurosci. Res. 28, 110-114.
68. Wion D., Neveu I., Jehan F., and Brachet P. (1992) Pertussis toxin provides evidence for two independent signalling pathways leading to the activation of the nerve growth factor gene. J. Neurosci. Res. 31, 294-300.
69. Woodroofe M. N., Sarna G. S., Wadhwa M., Hayes G. M., Loughlin A. J., Tinker A., and Cuzner M. L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J. Neuroimmunol. 33, 227-236.
70. Yakovlev A. G., De Bernardi M. A., Fabrazzo M., Brooker G., Costa E., and Mocchetti I. (1990) Regulation of nerve growth factor receptor mRNA content by dexamethasone: in vitro and in vivo studies. Neurosci. Lett. 116, 216-220.
71. Zafra F., Castren E., Thoenen H., and Lindholm D. (1991) Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc. Natl. Acad. Sci. USA 88, 10037-10041.
72. Zhou J.-Y., Norman A. W., Chen D.-L., Sun G.-W., Uskokovic M., and Koeffler H. P. (1990) 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 prolongs survival time of leukemic mice. Proc. Natl. Acad. Sci. USA 87, 3929-3932.